Literature DB >> 33664663

Dopaminergic and Metabolic Correlations With Cognitive Domains in Non-demented Parkinson's Disease.

Linlin Han1, Jiaying Lu2, Yilin Tang1, Yun Fan1, Qisi Chen1, Ling Li2, Fengtao Liu1, Jian Wang1, Chuantao Zuo2, Jue Zhao1.   

Abstract

BACKGROUND: Accruing positron emission tomography (PET) studies have suggested that dopaminergic functioning and metabolic changes are correlated with cognitive dysfunction in Parkinson's disease (PD). Yet, the relationship between dopaminergic or cerebral metabolism and different cognitive domains in PD is poorly understood. To address this scarcity, we aimed to investigate the interactions among dopaminergic bindings, metabolic network changes, and the cognitive domains in PD patients.
METHODS: We recruited 41 PD patients, including PD patients with no cognitive impairment (PD-NC; n = 21) and those with mild cognitive impairment (PD-MCI; n = 20). All patients underwent clinical evaluations and a schedule of neuropsychological tests and underwent both 11C-N-2-carbomethoxy-3-(4-fluorophenyl)-tropane (11C-CFT) and 18F-fluorodeoxyglucose (18F-FDG) PET imaging.
RESULTS: 11C-CFT imaging revealed a significant positive correlation between executive function and striatal dopamine transporter (DAT) binding at both the voxel and regional levels. Metabolic imaging revealed that executive function correlated with 18F-FDG uptake, mainly in inferior frontal gyrus, putamen, and insula. Further analysis indicated that striatal DAT binding correlated strictly with metabolic activity in the temporal gyrus, medial frontal gyrus, and cingulate gyrus.
CONCLUSION: Our findings might promote the understanding of the neurobiological mechanisms underlying cognitive impairment in PD.
Copyright © 2021 Han, Lu, Tang, Fan, Chen, Li, Liu, Wang, Zuo and Zhao.

Entities:  

Keywords:  Parkinson’s disease; cognitive domain; dopamine transporter; glucose metabolism; mild cognitive impairment

Year:  2021        PMID: 33664663      PMCID: PMC7921728          DOI: 10.3389/fnagi.2021.627356

Source DB:  PubMed          Journal:  Front Aging Neurosci        ISSN: 1663-4365            Impact factor:   5.750


  45 in total

1.  Rey-Osterrieth complex figure: normative values in an Italian population sample.

Authors:  P Caffarra; G Vezzadini; F Dieci; F Zonato; A Venneri
Journal:  Neurol Sci       Date:  2002-03       Impact factor: 3.307

Review 2.  Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.

Authors:  Irene Litvan; Jennifer G Goldman; Alexander I Tröster; Ben A Schmand; Daniel Weintraub; Ronald C Petersen; Brit Mollenhauer; Charles H Adler; Karen Marder; Caroline H Williams-Gray; Dag Aarsland; Jaime Kulisevsky; Maria C Rodriguez-Oroz; David J Burn; Roger A Barker; Murat Emre
Journal:  Mov Disord       Date:  2012-01-24       Impact factor: 10.338

3.  Mayo's Older African Americans Normative Studies: norms for Boston Naming Test, Controlled Oral Word Association, Category Fluency, Animal Naming, Token Test, WRAT-3 Reading, Trail Making Test, Stroop Test, and Judgment of Line Orientation.

Authors:  John A Lucas; Robert J Ivnik; Glenn E Smith; Tanis J Ferman; Floyd B Willis; Ronald C Petersen; Neill R Graff-Radford
Journal:  Clin Neuropsychol       Date:  2005-06       Impact factor: 3.535

Review 4.  The neurobiological basis of cognitive impairment in Parkinson's disease.

Authors:  Glenda M Halliday; James B Leverenz; Jay S Schneider; Charles H Adler
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

Review 5.  Cognitive and behavioral disorders in Parkinson's disease: an update. I: cognitive impairments.

Authors:  Costanza Papagno; Luigi Trojano
Journal:  Neurol Sci       Date:  2017-10-17       Impact factor: 3.307

6.  Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT study.

Authors:  Flavio Nobili; Claudio Campus; Dario Arnaldi; Fabrizio De Carli; Gaia Cabassi; Andrea Brugnolo; Barbara Dessi; Silvia Morbelli; Gianmario Sambuceti; Giovanni Abbruzzese; Guido Rodriguez
Journal:  Mov Disord       Date:  2010-01-15       Impact factor: 10.338

7.  Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease.

Authors:  Françoise J Siepel; Kolbjørn S Brønnick; Jan Booij; Bernard M Ravina; Alexander V Lebedev; Joana B Pereira; Renate Grüner; Dag Aarsland
Journal:  Mov Disord       Date:  2014-10-04       Impact factor: 10.338

8.  Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in 18 F-FDG PET imaging.

Authors:  Lei Wu; Feng-Tao Liu; Jing-Jie Ge; Jue Zhao; Yi-Lin Tang; Wen-Bo Yu; Huan Yu; Tim Anderson; Chuan-Tao Zuo; Ling Chen; Jian Wang
Journal:  Hum Brain Mapp       Date:  2018-07-12       Impact factor: 5.038

9.  The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study.

Authors:  Thomas Foltynie; Carol E G Brayne; Trevor W Robbins; Roger A Barker
Journal:  Brain       Date:  2003-12-22       Impact factor: 13.501

Review 10.  Clinical diagnostic criteria for dementia associated with Parkinson's disease.

Authors:  Murat Emre; Dag Aarsland; Richard Brown; David J Burn; Charles Duyckaerts; Yoshikino Mizuno; Gerald Anthony Broe; Jeffrey Cummings; Dennis W Dickson; Serge Gauthier; Jennifer Goldman; Christopher Goetz; Amos Korczyn; Andrew Lees; Richard Levy; Irene Litvan; Ian McKeith; Warren Olanow; Werner Poewe; Niall Quinn; Christina Sampaio; Eduardo Tolosa; Bruno Dubois
Journal:  Mov Disord       Date:  2007-09-15       Impact factor: 10.338

View more
  1 in total

Review 1.  Experimental Models of Cognitive Impairment for Use in Parkinson's Disease Research: The Distance Between Reality and Ideal.

Authors:  Yaohua Fan; Jiajun Han; Lijun Zhao; Chunxiao Wu; Peipei Wu; Zifeng Huang; Xiaoqian Hao; YiChun Ji; Dongfeng Chen; Meiling Zhu
Journal:  Front Aging Neurosci       Date:  2021-11-29       Impact factor: 5.750

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.